Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Jill Gilbert

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCHN1574

    03/21/2016

    A Randomized, Multicenter, Double-Blind Phase 2 Study of Palbociclib plus Cetuximab versus Cetuximab for the Treatment of Human Papillomavirus -Negative, Cetuximab-Naive Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck After Failure of One Prior Platinum-Containing Chemotherapy Regimen


    Print this page for your doctor